Related content

Circulating cell-free DNA: a potential biomarker in lung cancer

By Taylor Fiona   Teare M Dawn   Cox Angela   Woll Penella J  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 407-422

Future Medicine

Access to resources Recommend Favorite

Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice

By Zerbe Laura  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 605-620

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib in patients with advanced lung squamous cell carcinoma

By Chiang Chi-Lu   Tsai Chun-Ming   Chou Teh-Ying   Chen Yuh-Min   Lai Shinn-Liang   Shih Jen-Fu   Chiu Chao-Hua   Lee Yu-Chin  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 203-208

Springer Publishing Company

Access to resources Recommend Favorite

Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR

By            

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1400-1406

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG0803)

By Wu Y.-L.   Zhou C.   Cheng Y.   Lu S.   Chen G.-Y.   Huang C.   Huang Y.-S.   Yan H.-H.   Ren S.   Liu Y.   Yang J.-J.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 993-999

Oxford University Press

Access to resources Recommend Favorite